What Trump's Women's Health Executive Order Actually Says, Section by Section

Q: Does this order get rid of the NIH's existing women's health office?

No. The new division works in coordination with the Office of Research on Women's Health (est. 1990) — a sibling office with a broader mandate, not a replacement.

In 60 seconds: On October 19, President Trump signed Executive Order 14437, creating a new NIH Women's Health Division within 90 days and a White House task force co-chaired by RFK Jr. and Susie Wiles. We read all six sections of the actual order — here's what each one does, what it revokes, and the one thing it notably leaves out: new funding.

Key Takeaways

Executive Order 14437 was signed October 19 at a Rose Garden ceremony led by Melania Trump, who pushed the administration for the initiative and added her own signature to the order.
Section 2 orders HHS to stand up a Women's Health Division inside the NIH within 90 days — working alongside the existing Office of Research on Women's Health (founded 1990), not replacing it.
Sections 3 and 4 create a White House Women's Health Task Force, co-chaired by the HHS Secretary and the chief of staff, drawing in 11 agencies from Veterans Affairs to the FDA.
Section 5 wipes out the old framework: Biden's EO 14120 (March 2024) and the November 2023 women's health memorandum are revoked.
What's missing: a single dollar. Section 6 makes everything "subject to the availability of appropriations," and the order names no new funding.

The NIH Clinical Center in Bethesda, Maryland, part of the National Institutes of Health institute network — The National Institutes of Health Clinical Center in Bethesda, Maryland. The executive order directs HHS, acting through the NIH Director, to establish a new Women's Health Division inside the NIH's institute network within 90 days. Photo: public domain, via Wikimedia Commons.

What happened

On Monday, October 19, President Donald Trump stood in the White House Rose Garden and signed an executive order he didn't come up with himself. That credit goes to First Lady Melania Trump — who, per USA Today's reporting, spent weeks in working sessions with doctors, HHS officials, and outside experts shaping the initiative. She stood beside him at the ceremony and — in a flourish almost nobody does — added her own signature to the order after his.

The president's own reaction was the soundbite of the day: "They've been after it for a long time. When I heard about it, I said, 'Are you sure they don't have that?' Who the hell wouldn't have a woman's health division?"

Technically, the NIH does have an Office of Research on Women's Health — since 1990. What it doesn't have is a full division. And that distinction, plus everything else in the order's six sections, is worth understanding exactly — the wording is narrower, and in some ways bolder, than the signing-day headlines suggested. (Our coverage of the Rose Garden signing.)

Latest verified facts

The order — registered as Executive Order 14437 and titled "Advancing Women's Health to Improve Outcomes in All Phases of Life" — runs six sections. Here's each, in plain English:

Section 1: The case for acting

The "why." Diseases and conditions that uniquely or disproportionately affect women haven't gotten research and clinical attention on par with others, the order states — then lists them: heart disease, cancer, stroke, Alzheimer's, autoimmune and inflammatory conditions, osteoporosis, mental health, chronic pain, endometriosis, fibroids, ovarian conditions, infertility, maternal health, menopause, neurological disorders, and aging. The stated policy: stage-specific prevention, diagnosis, treatment, and care from infancy through aging.

Section 2: A new NIH division — within 90 days

The teeth. The HHS Secretary, acting through the NIH Director, shall establish a Women's Health Division inside an appropriate NIH institute or center within 90 days of signing — so, roughly by mid-January 2027. Its seven jobs: expand scientific review of understudied women's health conditions (including replication studies); coordinate research across life stages; speed up diagnosis with new technologies; strengthen interdisciplinary research; improve data methods and the inclusion of women and girls in clinical trials; enforce accountability on the NIH rule requiring research to account for sex as a biological variable; and push discoveries out of journals into actual clinical practice. It works with the 1990 office, not instead of it.

Sections 3 and 4: The task force

A White House Women's Health Task Force, co-chaired by HHS Secretary Robert F. Kennedy Jr. and White House Chief of Staff Susie Wiles. The membership list tells you this is bigger than HHS: alongside the FDA commissioner, CDC director, NIH director, ARPA-H director, and CMS administrator sit the secretaries of Veterans Affairs, Agriculture, Labor, and Education — plus the EPA administrator and, yes, the "Secretary of War." The task force can hold public hearings, pull in private-sector and philanthropy experts, and is charged with advancing the science, translating it into clinical practice, pushing patient-centered care and provider supply chains, and breaking down agency silos.

Section 5: The old orders are gone

Two lines, big signal. Revoked: Executive Order 14120 — Biden's March 18, 2024 women's health order — and the November 13, 2023 White House memorandum. This replaces the Biden framework; it doesn't build on it.

Section 6: The fine print

Standard boilerplate with real bite: implementation is "consistent with applicable law and subject to the availability of appropriations," creates no rights enforceable by anyone — and HHS foots the bill for publishing the order itself. Translation: everything the order demands still has to survive Congress's budget process.

Aerial view of the National Institutes of Health campus in Bethesda, Maryland — An aerial view of the NIH campus in Bethesda, Maryland. The new task force spans 11 agencies — from Veterans Affairs to the FDA — to coordinate women's health research across the federal government. Photo: public domain, via Wikimedia Commons.

Why it matters

Strip away the ceremony and there's a legitimate gap at the center. The NIH spends roughly $5 billion a year on women's health research — about 10% of its budget, per NIH data cited by USA Today and Becker's — and yet conditions that predominantly affect women have long been research's poor cousins. NIH Director Jay Bhattacharya's line in the HHS release: the division will "help close lingering evidence gaps, expand and maximize the impact of our research investments, and bring discoveries closer to patients."

Experts were, on balance, welcoming — the Society for Women's Health Research, the American College of Obstetricians and Gynecologists, and the Women First Research Coalition said so jointly. But USA Today's follow-up surfaced the tension the Rose Garden ceremony skipped: this administration has spent its second term cutting research grants it labeled "illegal DEI," including grants aimed at women's issues. So the question hanging over the order is whether the new division is a real reversal or just new letterhead on a shrinking budget. And the politics are obvious — the signing landed about two weeks before the midterms, with Trump's approval among women at 29%, per AP reporting.

Impact on the USA and the world

For Americans, the near-term impact is institutional, not personal — nothing here changes your healthcare tomorrow, and Section 6 says so explicitly. But the grant-accountability piece could quietly matter: the NIH has long required funded researchers to account for sex as a biological variable, and enforcement has been uneven. A division whose job includes developing real accountability for that rule could change what gets funded and what trials look like — which eventually changes what treatments reach women.

Globally, it's a domestic document with no international provisions. But if the division accelerates AI-driven discovery in under-researched conditions — part of Melania Trump's five-point framework — the science, published openly, doesn't stop at the border.

What happens next

Watch the 90-day clock: HHS has until roughly mid-January 2027 to stand up the division, and the clock is already running. After that, three things decide whether this is policy or pageantry: whether the task force's public hearings produce measurable commitments; whether Congress funds any of it — the "subject to appropriations" clause is where executive orders go to be ignored; and whether the administration's own grant-cutters give the new division anything to work with.

One honest caveat: executive orders can be reversed with a signature. Section 5 proves it — this order does to Biden's women's health order exactly what a future order could do to it. The real test starts now: staffing, funding, and follow-through.

Frequently asked questions

Does this order get rid of the NIH's existing women's health office?

No. The new division works "in coordination with" the Office of Research on Women's Health (est. 1990) — a sibling office with a broader mandate, not a replacement.

Does the order include any funding?

No dollar figure appears anywhere in it. Section 6(b) makes everything "subject to the availability of appropriations," and no official has named a budget. Context: the NIH already spends about $5 billion a year on women's health — roughly 10% of its budget.

Wasn't there already a women's health executive order?

Yes — Biden's EO 14120 (March 2024) and a November 2023 memorandum. Section 5 revokes both; this order replaces that framework rather than building on it.

When will the new NIH division actually exist?

The order gives HHS 90 days from October 19, 2026 — roughly mid-January 2027 — to establish the division. That deadline is the order's first real test.

Does this change my healthcare right now?

Not directly. It builds research and coordination infrastructure, and Section 6 says it creates no enforceable rights or benefits. Any effect on care would come years later, through funded research.